ARTICLE | Financial News
NuCana raises $100M IPO
September 29, 2017 9:41 PM UTC
On Sept. 27, cancer company NuCana plc (NASDAQ:NCNA) raised $100 million through the sale of 6.7 million ADSs at $15 in its IPO underwritten by Citigroup, Jefferies, Cowen and William Blair. Each ADS represents one ordinary share. NuCana's pipeline includes Acelarin, which is in multiple clinical trials to treat cancer...